Literature DB >> 8900165

Functional requirements of the active site position 185 in the human enzyme galactose-1-phosphate uridylyltransferase.

B B Quimby1, L Wells, K D Wilkinson, J L Fridovich-Keil.   

Abstract

The active site of galactose-1-phosphate uridylyltransferase (GALT) includes a HPH sequence that has been conserved in all species examined from Escherichia coli to humans. The crystal structure of the E. coli enzyme suggests that this proline is important in positioning the active site histidine (His-166) near the substrate. To examine the role of this proline in the homologous human sequence, we have performed saturating mutagenesis at Pro-185 within human GALT and characterized each resultant mutant enzyme using a yeast expression system. Activity analyses in crude lysates indicated that only proline at position 185 produced wild-type levels of activity, although five other amino acids, Ala, Gly, Ser, Gln, and Glu, all produced partially active enzymes. Western blot analyses of the GALT proteins in these lysates demonstrated that abundance varied from 9-118% of wild-type and was independent of activity. All five active mutant proteins were purified and characterized with regard to specific activity, apparent Km for both substrates, and temperature-dependence of activity. Finally, modeling of these mutations onto the conserved E. coli active site structure was performed. Together, these results provide functional evidence demonstrating the critical role of Pro-185 in facilitating the transferase reaction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8900165     DOI: 10.1074/jbc.271.43.26835

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Biochemical characterization of the S135L allele of galactose-1-phosphate uridylyltransferase associated with galactosaemia.

Authors:  L Wells; J L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

2.  Characterization of two mutations associated with epimerase-deficiency galactosemia, by use of a yeast expression system for human UDP-galactose-4-epimerase.

Authors:  B B Quimby; A Alano; S Almashanu; A M DeSandro; T M Cowan; J L Fridovich-Keil
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

3.  A frequent splicing mutation and novel missense mutations color the updated mutational spectrum of classic galactosemia in Portugal.

Authors:  Ana I Coelho; Ruben Ramos; Ana Gaspar; Cláudia Costa; Anabela Oliveira; Luísa Diogo; Paula Garcia; Sandra Paiva; Esmeralda Martins; Elisa Leão Teles; Esmeralda Rodrigues; M Teresa Cardoso; Elena Ferreira; Sílvia Sequeira; Margarida Leite; Maria João Silva; Isabel Tavares de Almeida; João B Vicente; Isabel Rivera
Journal:  J Inherit Metab Dis       Date:  2013-06-08       Impact factor: 4.982

4.  Studies of the V94M-substituted human UDPgalactose-4-epimerase enzyme associated with generalized epimerase-deficiency galactosaemia.

Authors:  T M Wohlers; J L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2000-11       Impact factor: 4.982

5.  Misfolding of galactose 1-phosphate uridylyltransferase can result in type I galactosemia.

Authors:  Thomas J McCorvie; Tyler J Gleason; Judith L Fridovich-Keil; David J Timson
Journal:  Biochim Biophys Acta       Date:  2013-04-11

Review 6.  Galactose toxicity in animals.

Authors:  Kent Lai; Louis J Elsas; Klaas J Wierenga
Journal:  IUBMB Life       Date:  2009-11       Impact factor: 3.885

7.  Classic galactosaemia in the Greek Cypriot population: An epidemiological and molecular study.

Authors:  Rena Papachristoforou; Petros P Petrou; Hilary Sawyer; Maggie Williams; Anthi Drousiotou
Journal:  Ann Hum Genet       Date:  2019-04-17       Impact factor: 1.670

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.